Skip to main content
Quest Diagnostics

Severe Hypothyroidism With Paradoxically Elevated Direct Free T4 Due To Anti-thyroxine Antibodies

Endocrine Society's Annual Meeting

ENDO 2023

Chicago, IL, June 15-18, 2023

Poster presentation: Severe Hypothyroidism With Paradoxically Elevated Direct Free T4 Due To Anti-thyroxine Antibodies

Authors:  Magvanjav O, McPhaul MJ, Choucair I, Holt E

Specialty: Cardiovascular disease, Cardiology, Endocrinology, Infectious disease

Related content

Conference Presentation
Diagnostic utility of next-generation sequencing panel testing for individuals with suspected congenital hypothyroidism or resistance to thyroid hormone
Conference Presentation
1 in 5 patients with suspected congenital hypothyroidism or resistance to thyroid hormone receive a molecular diagnostic result using multi-gene panel testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.